Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Molecular Pharmaceutics|June 15, 2010
Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitroZhenkun Zhu, Xin Xu, Yanke Yu, et al.
Environmental Science & Technology|July 21, 2025
Rationally Engineered CuSO4/TiO2 with Cl Desorption and Intermediate Rapid Oxidation Dual-Reaction Channels for Efficacious 1,2-Dichloroethane Deep DestructionMingjiao Tian, Jianrong Li, Han Xu, et al.
Expert Review of Respiratory Medicine|February 26, 2011
Role of CCR2 and IL-8 in acute lung injury: a new mechanism and therapeutic targetYao Shen, Diane Wang, Xiangdong Wang
Ophthalmic Plastic and Reconstructive Surgery|September 22, 2022
Tarsal Ectropion Repair With Modified Bick Eyelid Tightening and Inverting SuturesDiane Wang, Wenyu Deng, Roman Shinder
Mutation Research|January 21, 2006
DNA damage evaluated by gammaH2AX foci formation by a selective group of chemical/physical stressorsChunxian Zhou, Zhongxiang Li, Huiling Diao, et al.
Journal of Clinical Pharmacology|December 18, 2013
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjectsYanke Yu, Veronika Logovinsky, Edgar Schuck, et al.
Journal of Clinical Pharmacology|May 30, 2020
Talazoparib Exposure-Efficacy Analysis in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations in the EMBRACA TrialYanke Yu, Mohamed Elmeliegy, Jennifer K Litton, et al.
Investigational New Drugs|July 27, 2013
Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cellsMancang Gu, Yanke Yu, G M Kamal B Gunaherath, et al.
Molecular Pharmaceutics|September 18, 2010
Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug releasePeng Zou, Yanke Yu, Y Andrew Wang, et al.
Journal of Clinical Pharmacology|November 25, 2025
Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration-Resistant Prostate CancerMark Hadigol, Jason H Williams, Haihong Shi, et al.
Pageof 15